by The global aesthetic medicine market size is expected to be worth around US$ 130.7 billion by 2030, according to a new report by Vision Research Reports.
The global aesthetic medicine market size was valued at US$ 87.6 billion in 2020 and is anticipated to grow at a CAGR of 10.8% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38817
Table of Contents
Aesthetic Medicine Market Growth Factors
According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is ‘a branch of medicine focused on satisfying the aesthetic desires and goals of patient. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Key drivers of the market include introduction of non-invasive medical devices for cosmetic procedures, growing focus on physical appearance, and rise in adoption among geriatric individuals.
Aesthetic Medicine Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 130.7 Bn by 2030 |
| Growth Rate | CAGR of 10.8% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Procedure Type |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Allergan; Hologic (cynosure); Johnson & Johnson; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser |
By Procedure Type Analysis
The non-invasive procedures segment dominated the market for aesthetic medicine and accounted for the largest revenue share of 52.5% in 2020. The segment is expected to witness the fastest CAGR over the forecast period.
Invasive procedures such as liposuction, breast augmentation, nose reshaping, are some of the popular aesthetic procedures. Growing focus towards physical appearance has increased demand for these invasive procedures.
By Regional Analysis
North America accounted for the largest share of 36.0% in the market for aesthetic medicine. Advanced healthcare infrastructure, adoption of cosmetic procedures, increasing prevalence of skin disorders, and the presence of board certified and skilled cosmetic surgeons in the region are some of the major factors contributing to the growth of the aesthetic medicine market in this region.
In Asia Pacific, the market for aesthetic medicine is projected to witness the highest CAGR of 10.9% during the forecast period. The region is backed by countries such as China, India, and South Korea.
Read also @ Magnetic Resonance Imaging Market to Reach US$ 20.7 Bn by 2030
Major Key Players Covered in The Aesthetic Medicine Market Report include
- Allergan
- Hologic (cynosure)
- Johnson & Johnson
- Galderma
- Lumenis
- Solta Medical
- Syneron Candela
- Alma Laser
Aesthetic Medicine Market Segmentation
- By Procedure Type
- Invasive Procedures
- Breast augmentation
- Liposuction
- Nose reshaping
- Eyelid Surgery
- Tummy tuck
- Others
- Non-invasive Procedures
- Botox injections
- Soft tissue fillers
- Chemical peel
- Laser hair removal
- Microdermabrasion
- Others
- Invasive Procedures
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- India
- Japan
- China
- Australia
- New Zealand
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Aesthetic Medicine Market, By Procedure Type
7.1. Aesthetic Medicine Market, by Procedure Type, 2021-2030
7.1.1. Invasive Procedures
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Non-invasive Procedures
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
Chapter 9. Company Profiles
9.1. Allergan
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Hologic (cynosure)
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Johnson & Johnson
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Galderma
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Lumenis
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Solta Medical
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Syneron Candela
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Alma Laser
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38817
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
